The drug-drug interaction between proton pump inhibitors and clopidogrel
Open Access
- 31 March 2009
- journal article
- editorial
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 180 (7) , 699-700
- https://doi.org/10.1503/cmaj.090251
Abstract
The efficacy of clopidogrel in combination with acetylsalicylic acid (ASA) therapy has been clearly established in well-designed randomized controlled trials that have shown a reduction in recurrent coronary events following acute myocardial infarction, as compared with ASA monotherapy.[1][1]Keywords
This publication has 12 references indexed in Scilit:
- A population-based study of the drug interaction between proton pump inhibitors and clopidogrelCMAJ : Canadian Medical Association Journal, 2009
- Cytochrome P-450 Polymorphisms and Response to ClopidogrelNew England Journal of Medicine, 2009
- Genetic Determinants of Response to Clopidogrel and Cardiovascular EventsNew England Journal of Medicine, 2009
- The Effect of CYP2C19 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Clopidogrel: A Possible Mechanism for Clopidogrel ResistanceClinical Pharmacology & Therapeutics, 2008
- Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With AspirinJournal of the American College of Cardiology, 2008
- Cytochrome P450 3A Inhibition by Ketoconazole Affects Prasugrel and Clopidogrel Pharmacokinetics and Pharmacodynamics DifferentlyClinical Pharmacology & Therapeutics, 2007
- COMPARISON OF INHIBITORY EFFECTS OF THE PROTON PUMP-INHIBITING DRUGS OMEPRAZOLE, ESOMEPRAZOLE, LANSOPRAZOLE, PANTOPRAZOLE, AND RABEPRAZOLE ON HUMAN CYTOCHROME P450 ACTIVITIESDrug Metabolism and Disposition, 2004
- The Influence of St. John's Wort on CYP2C19 Activity with Respect to GenotypeThe Journal of Clinical Pharmacology, 2004
- Atorvastatin Reduces the Ability of Clopidogrel to Inhibit Platelet AggregationCirculation, 2003
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001